Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study

被引:33
作者
Zingel, Rebecca [1 ]
Bohlken, Jens [2 ]
Kostev, Karel [1 ]
机构
[1] IQVIA, Epidemiol, Unterschweinstiege 2-14, D-60549 Frankfurt, Germany
[2] Univ Leipzig, Med Fac, Inst Social Med Occupat Med & Publ Hlth ISAP, Leipzig, Germany
关键词
Crohn's disease; dementia; inflammatory bowel disease; ulcerative colitis; CROHNS-DISEASE; EPIDEMIOLOGY; PERSISTENCE; MORTALITY; RISK;
D O I
10.3233/JAD-210103
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The critical role of inflammatory processes in the pathogenesis of dementia has recently been established. Objective: The aim of this study was to investigate the association between inflammatory bowel disease (IBD) and dementia risk in patients followed in general practices in Germany. Methods: This study included patients aged over 60 with an initial diagnosis of IBD (Crohn's Disease (CD), ulcerative colitis (UC)) who were followed in 1,159 German general practices between January 1995 and December 2014. IBD patients were matched to healthy patients using propensity scores based on age, gender, index year, insurance type and comorbidities. Kaplan-Meier curves were used to study the development of dementia in patients with or without IBD within up to 15 years of the index date. Cox proportional hazard regression models were used to estimate the relationship between IBD and dementia. Results: The study included 3,850 patients with and 3,850 patients without IBD and revealed a higher cumulative incidence of dementia in IBD patients than in non-IBD patients after the follow-up period. The cumulative incidence of dementia differed within IBD subtypes; it was significantly higher in UC patients than in CD patients. Cox proportional hazard models showed that IBD is associated with a 1.22-fold increase in the risk (95% CI: 1,07-1,39) of developing dementia. UC patients had a 1.25-fold higher risk of developing dementia (95% CI: 1.07-1.46). CD is not significantly associated with an increased risk of dementia (HR: 1.17, 95% CI: 0.93-1.47). Conclusion: A positive association between IBD and dementia was found in patients followed in general practices in Germany.
引用
收藏
页码:1471 / 1478
页数:8
相关论文
共 44 条
  • [1] The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Alatab, Sudabeh
    Sepanlou, Sadaf G.
    Ikuta, Kevin
    Vahedi, Homayoon
    Bisignano, Catherine
    Safiri, Saeid
    Sadeghi, Anahita
    Nixon, Molly R.
    Abdoli, Amir
    Abolhassani, Hassan
    Alipour, Vahid
    Almadi, Majid A. H.
    Almasi-Hashiani, Amir
    Anushiravani, Amir
    Arabloo, Jalal
    Atique, Suleman
    Awasthi, Ashish
    Badawi, Alaa
    Baig, Atif A. A.
    Bhala, Neeraj
    Bijani, Ali
    Biondi, Antonio
    Borzi, Antonio M.
    Burke, Kristin E.
    Carvalho, Felix
    Daryani, Ahmad
    Dubey, Manisha
    Eftekhari, Aziz
    Fernandes, Eduarda
    Fernandes, Joao C.
    Fischer, Florian
    Haj-Mirzaian, Arvin
    Haj-Mirzaian, Arya
    Hasanzadeh, Amir
    Hashemian, Maryam
    Hay, Simon, I
    Hoang, Chi L.
    Househ, Mowafa
    Ilesanmi, Olayinka S.
    Balalami, Nader Jafari
    James, Spencer L.
    Kengne, Andre P.
    Malekzadeh, Masoud M.
    Merat, Shahin
    Meretoja, Tuomo J.
    Mestrovic, Tomislav
    Mirrakhimov, Erkin M.
    Mirzaei, Hamed
    Mohammad, Karzan A.
    Mokdad, Ali H.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 17 - 30
  • [2] Alzheimer's Disease International, 2019, WORLD ALZHEIMER REPO
  • [3] Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
    Baumgart, Daniel C.
    Carding, Simon R.
    [J]. LANCET, 2007, 369 (9573) : 1627 - 1640
  • [4] Association Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study
    Bohlken, Jens
    Jacob, Louis
    Kostev, Karel
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (02) : 725 - 732
  • [5] Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany
    Bohlken, Jens
    Jacob, Louis
    Kostev, Karel
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (01) : 37 - 44
  • [6] Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels
    Bonfili, Laura
    Cecarini, Valentina
    Berardi, Sara
    Scarpona, Silvia
    Suchodolski, Jan S.
    Nasuti, Cinzia
    Fiorini, Dennis
    Boarelli, Maria Chiara
    Rossi, Giacomo
    Eleuteri, Anna Maria
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [7] Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative
    Bryant, R. V.
    Winer, S.
    Travis, S. P. L.
    Riddell, R. H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 (12) : 1582 - 1597
  • [8] The epidemiology of inflammatory bowel disease
    Burisch, Johan
    Munkholm, Pia
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (08) : 942 - 951
  • [9] Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010
    Caini, Saverio
    Bagnoli, Siro
    Palli, Domenico
    Saieva, Calogero
    Ceroti, Marco
    Bendinelli, Benedetta
    Assedi, Melania
    Masala, Giovanna
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1162 - 1167
  • [10] Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
    Coupland, Carol A. C.
    Hill, Trevor
    Dening, Tom
    Morriss, Richard
    Moore, Michael
    Hippisley-Cox, Julia
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1084 - 1093